142 related articles for article (PubMed ID: 8823276)
1. Absorbed dose distribution of the auger emitters 67GA and 125I and the beta-emitters 67CU, 90Y, 131I, and 186RE as a function of tumor size, uptake, and intracellular distribution.
van Dieren EB; Plaizier MA; van Lingen A; Roos JC; Barendsen GW; Teule GJ
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):197-204. PubMed ID: 8823276
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
3. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
[TBL] [Abstract][Full Text] [Related]
4. A dosimetric model for intrathecal treatment with 131I and 67Ga.
van Dieren EB; van Lingen A; Roos JC; Huijgens PC; Barendsen GW; Teule GJ
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):447-54. PubMed ID: 7928472
[TBL] [Abstract][Full Text] [Related]
5. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
[TBL] [Abstract][Full Text] [Related]
6. Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5.
Reiner D; Blaickner M; Rattay F
Med Phys; 2009 Nov; 36(11):4890-6. PubMed ID: 19994497
[TBL] [Abstract][Full Text] [Related]
7. Low-energy electron emitters for targeted radiotherapy of small tumours.
Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors.
Howell RW; Rao DV; Sastry KS
Med Phys; 1989; 16(1):66-74. PubMed ID: 2921982
[TBL] [Abstract][Full Text] [Related]
9. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
[TBL] [Abstract][Full Text] [Related]
11. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
Bardiès M; Chatal JF
Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
[TBL] [Abstract][Full Text] [Related]
12. Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.
Shinohara A; Hanaoka H; Sakashita T; Sato T; Yamaguchi A; Ishioka NS; Tsushima Y
Ann Nucl Med; 2018 Feb; 32(2):114-122. PubMed ID: 29238922
[TBL] [Abstract][Full Text] [Related]
13. Model of metastatic growth valuable for radionuclide therapy.
Bernhardt P; Ahlman H; Forssell-Aronsson E
Med Phys; 2003 Dec; 30(12):3227-32. PubMed ID: 14713089
[TBL] [Abstract][Full Text] [Related]
14. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.
Bao A; Zhao X; Phillips WT; Woolley FR; Otto RA; Goins B; Hevezi JM
Med Phys; 2005 Jan; 32(1):200-8. PubMed ID: 15719971
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4.
Strigari L; Menghi E; D'Andrea M; Benassi M
Med Phys; 2006 Sep; 33(9):3383-9. PubMed ID: 17022234
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography.
Muthuswamy MS; Roberson PL; Ten Haken RK; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):165-72. PubMed ID: 8641915
[TBL] [Abstract][Full Text] [Related]
17. EGS4 Monte Carlo determination of the beta dose kernel in water.
Simpkin DJ; Mackie TR
Med Phys; 1990; 17(2):179-86. PubMed ID: 2333044
[TBL] [Abstract][Full Text] [Related]
18. [Dosimetry and radiation dose distribution in tumors for radioimmunotherapy: the effect of tumor size].
Fujimori K; Furudate M
Kaku Igaku; 1994 Mar; 31(3):241-8. PubMed ID: 8176862
[TBL] [Abstract][Full Text] [Related]
19. Absorbed fractions for electrons and beta particles in spheres of various sizes.
Siegel JA; Stabin MG
J Nucl Med; 1994 Jan; 35(1):152-6. PubMed ID: 8271037
[TBL] [Abstract][Full Text] [Related]
20. Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy.
Botta F; Mairani A; Battistoni G; Cremonesi M; Di Dia A; Fassò A; Ferrari A; Ferrari M; Paganelli G; Pedroli G; Valente M
Med Phys; 2011 Jul; 38(7):3944-54. PubMed ID: 21858991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
